-+ 0.00%
-+ 0.00%
-+ 0.00%

Annovis Bio Q3 EPS $(0.37) Misses $(0.30) Estimate

Benzinga·11/12/2025 13:11:28
Listen to the news
Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.30) by 21.31 percent. This is a 61.86 percent increase over losses of $(0.97) per share from the same period last year.